The visionary founder and CEO of Imaginostics, Codi Amir Gharagouzloo. Not only a trailblazer in his professional life but also possesses a passion for baseball. Codi is a true innovator in the field of medical imaging and health technology.
Imaginostics is a pioneering health and longevity tech startup dedicated to advancing magnetic resonance imaging (MRI) biomarkers. Their innovative technology holds the potential to revolutionize the diagnosis and treatment of various medical conditions across multiple fields, including neurology, cardiology, and oncology.
With a strong background in MRI physics and expertise in nanoparticle contrast-enhanced imaging, Codi is the brilliant mind behind the Quantitative Ultra-short Time-to-echo Contrast-Enhanced (QUTE-CE) MRI method, affectionately known as "cute-see."
This groundbreaking MRI method was conceived during their doctoral studies in Bioengineering at Northeastern University and further developed during their T-32 postdoctoral fellowship at the Gordon Center for Medical Imaging at Massachusetts General Hospital and Harvard Medical School.
Following this remarkable journey, they founded Imaginostics to bring this revolutionary technology to the forefront of medical innovation.
At the core of Imaginostics' offerings is the QUTE-CE MRI software suite, which features renal-safe vascular imaging technology, delivering a remarkable 10-fold enhancement in soft tissue imaging without the use of harmful gadolinium agents. This suite also provides a unique panel of precision medicine biomarkers for assessing vascular structure, function, and leakage. Compatible with existing MRI scanners, this technology has the power to stratify patient populations, enable early disease diagnosis, and evaluate drug efficacy in clinical trials.
Codi’s passion for healthy aging and its unwavering commitment to protecting physical and mental well-being resonates with its mission. They firmly believe that everyone should have the opportunity to age gracefully and live a fulfilling life. Their ultimate goal is to empower patients with advanced prognostic information, helping them prepare for the future and participate in clinical trials as part of the collective effort to find cures for various diseases.
Timestamp:
00:04:29 Early detection of Alzheimer's.
00:04:53 Blood-brain barrier leakage and cognitive impairment.
00:11:50 Importance of parental involvement in education.
00:14:02 Education system lacks resources and opportunities in certain towns.
00:21:49. Revolutionary imaging software for health hazards.
00:24:43 Early detection of neurodegenerative diseases.
00:28:45 Data-driven approach for medical research.
00:34:07 Developing advanced imaging for Alzheimer's.
Thank you for tuning in to this episode The Rocket Scientist Exploring Alzheimer's and Early Detection with Codi Amir Gharagouzloo. We hope you found our conversation inspiring and informative. Remember, unlocking your potential is a journey; with the right mindset, you can achieve incredible success.
Be sure to subscribe to our podcast for more inspiring interviews and valuable insights. If you enjoyed this episode, please leave us a review and share it with your network. Together, we can unlock success!
Disclaimer: The views and opinions expressed in this podcast are those of the host and guest and do not necessarily reflect the official policy or position of any organization.
Connect with Codi Amir Gharagouzloo
LinkedIn
Website
Ready to take your game to the next level? Join the NIL movement and discover a world of new opportunities!
https://www.aim4nil.com/
Support our sponsors:
www.rebelliousbeverage.com
Learn more about Leadershipity Coaching and Events:
Trent@leadershipity.com
Connect with Coach Trent Clark with these links :
Youtube: https://www.youtube.com/channel/UC_76SFCClh6GbqLjzFgf8xw
LinkedIn: https://www.linkedin.com/in/trentmclark/
Instagram:https://www.instagram.com/leadershipity/?hl=en
Fb Page: https://www.facebook.com/Leadershipity/?ref=pages_you_manage
